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Two new protostemonine-type alkaloids, javastemonine A and B (3 and 4) have been isolated 
from the root extracts of Stemona javanica together with four known Stemona alkaloids, 13-
demethoxy-11(S*),12(R*)-dihydroprotostemonine (1), isoprotostemonine (2), protostemonine 
and isomaistemonine. The structures and relative configurations of the new alkaloids were 
determined by spectroscopic analysis. The alkaloids 1 and 2 and protostemonine showed 
moderated antiplasmodial activities against the Plasmodium falciparum strains, TM4 (IC50 
values of 17.7 ± 3.7, 16.8 ± 5.4, 16.0 ± 4.2 µg/mL, respectively) and K1 (IC50 values of 16.8 
± 3.1, 14.1 ± 3.7, 11.9 ± 3.3 µg/mL, respectively). These compounds showed no significant 
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acetylcholinesterase, cytotoxicity.   
 
1. Introduction 
The Stemonaceae family comprises three genera, Stemona, Croomia and Stichoneuron 
(Inthachub et al., 2009). Extracts of the roots of the Stemona species have been used in 
traditional medicine to treat the symptoms of bronchitis, pertussis and tuberculosis and as 
anti-parasitics on humans and animals (Greger, 2006; Kongkiatpaiboon, 2001, Pilli et al., 
2010, 2005). More than 190 unique Stemona alkaloids have been isolated, some of these have 
significant antitussive activity (Chung et al., 2003; Lin et al., 2008a, 2008b, 2006; Xu et al., 
2010, 2006; Yang et al., 2009; Zhou et al., 2009;), as well as insect toxicity, antifeedant, and 
repellent activities (Brem et al., 2002; Jiwajinda et al., 2001; Kaltenegger et al., 2003; 
Kongkiatpaiboon et al., 2013, 2012; Mungkornasawakul et al., 2009, 2004a; Phattharaphan et 
al., 2010; Sanguanpong and Hummel, 2008; Sakata et al., 1978; Tang et al., 2008). These 
latter properties are most likely associated with the ability of these alkaloids to inhibit insect 
acetylcholinesterase (AChE) (Brem et al., 2002; Jiwajinda et al., 2001; Kaltenegger et al., 
2003; Kongkiatpaiboon et al, 2013, 2012; Mungkornasawakul et al., 2009, 2004; 
Phattharaphan et al., 2010; Sanguanpong and Hummel 2008; Sakata et al., 1978; Sastraruji et 
al., 2012; Tang et al., 2008). While other alkaloids have shown oxytocin antagonism 
(Phuwapraisirisan et al., 2006), nitric oxide inhibition (Hosoya et al., 2011) and the ability to 
inhibit P-glycoprotein in multi-drug-resistant cancer cell lines (Chanmahasathien et al., 
2011a, 2011b; Limtrakul et al., 2007; Umsumarng et al., 2013). In the present paper, we 
describe the results of our phytochemical investigation of the roots of S. javanica collected 




2. Results and discussion 
The roots of S. javanica were collected from Alas Purwo, East of Java, Indonesia in June and 
December 2012. Successive purification of the crude MeOH extract (35.2 g) by column 
chromatography gave pure samples of 13-demethoxy-11(S*),12(R*)-dihydroprotostemonine 
(1) (Tang et al., 2008), protostemonine (Kaltenegger et al., 2003), isoprotostemonine (2) (Ye 
et al., 1994), isomaistemonine (Guo et al., 2008), and two new Stemona alkaloids, 
javastemonine A (3) and javastemonine B (4) (Figure 1).  
 
Compounds 3 and 4 are new compounds; we have named these alkaloids based on 
their botanical origins. Compound 3 was obtained as a brown gum. Its molecular formula was 
determined as C22H32NO5 from its HRESIMS (m/z 390.2280 [M+H]
+, calc. for 390.2291). 
The IR spectrum of 3 showed characteristic bands at 1771 cm-1 and at 1761 and 1657 cm-1 for 
a saturated and an unsaturated -lactone, respectively. The 13C/DEPT NMR spectrum 
displayed resonances for three methyl [δ 15.9 (C-17), 15.1 (C-22) and 11.0 (C-16)], six 
methylene [δ 48.0 (C-5), 35.3 (C-7), 34.9 (C-19), 26.9 (C-1), 26.8 (C-2), and 19.8 (C-6)], five 
methine [δ 65.1 (C-3), 59.7 (C-9a), 54.6 (C-9), 39.8 (C-10), and 35.1 (C-20)], four 
oxymethine [δ 83.5 (C-11), 82.6 (C-18), 80.7 (C-12), and 80.6 (C-8)], two olefinic [δ 146.4 
(C-13) and 131.2 (C-14)] and two quaternary [δ 179.5 (C-21) and 174.5 (C-15)] carbons 
(Table 1). The H/H COSY correlations of 3 indicated the spin system H-1−H-2−H-3−H-
18−H-19−H-20−H-22, typical of the pyrrolidine ring of the Stemona alkaloids, with a -
lactone substituent at C-3 (Figure 2). Also observed were the COSY correlations between the 
vicinal pairs of contiguous protons along the C-5−C-13 and H-9−H-1 backbones and between 
H-10 and H-17 (Figure 2). The 1H NMR spectrum indicated resonances for two different 
methyl groups, which were attached to methine carbons, with 1H NMR resonances at δ 1.26 
(d, J = 7.0 Hz, 3H, H-22) and δ 1.10 (d, J = 6.5 Hz, 3H, H-17), and a singlet methyl 
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resonance at δ 1.95  (s, 3H, H-16). Key HMBC correlations for 3 are shown in Figure 2, 
while full details are provided in Table 1. HSQC and HMBC experiments identified the 
protons and carbons (C-18−C-22) of the γ-butyrolactone moiety (Figure 2), which was clearly 
attached to C-3 from the HMBC correlation between H-3 (δ 3.23, ddd, 6.6, 7.0, 10.0) and C-
18 (δ 82.6). HSQC and HMBC experiments further helped to identified the protons and 
carbons (C-11−C16) associated with the unsaturated γ-butyrolactone moiety of 3 (Figure 2). 
The 1H NMR spectra of 1, 3, and the known alkaloid stemocochinine 5 (Kaltenegger, 2003; 
Tang et al., 2008) were nearly superimposable, except for small, but noticeable differences in 
the chemical shifts of some 1H and 13C NMR resonances. Notably, the 1H NMR chemical 
shifts of H-9a and H-18 for these three compounds were significantly different [{1: H-9a (δ 
3.63, ddd, J = 5.0, 5.6, 10.5) and H-18 (δ 4.14, ddd, J = 5.3, 7.5, 11.1)}; {3: H-9a (δ 3.77-
3.75, overlap) and H-18 (δ 4.31, ddd, J = 5.5, 7.4, 12.8)}and {5: H-9a (δ 3.64, ddd, J = 9.8, 
4.9, 4.9) and H-18 (δ 4.14, ddd, J = 11.2, 7.9, 5.3)}] (Kaltenegger, 2003; Tang et al., 2008). 
These differences suggested that 3 was a diastereomer of 1 and 5. This assumption was also 
supported by their different chemical shifts for some 13C NMR resonances [{1: C-11 
(δC-12 (δ83.1) and C-18 (δ{3: C-11 (δC-12 (δ80.7) and C-18 
(δand {5: C-11 (δC-12 (δ80.5) and C-18 (δ(Kaltenegger, 2003; Tang 
et al., 2008). The relative configuration of 3 was established from analysis of the ROESY 
NMR correlations of 3 and was further supported by molecular modelling experiments. 
TOCSY-type artifacts, which have the same phase as the diagonal peaks, were essentially 
eliminated (not observed) in these ROESY experiments (ROESY cross peaks have the 
opposite phase) (Bax, 1985). Compound 3 showed ROESY correlations between H-9a and H-
1α, H-2α, H-3 and H-10 (Figure 3 and Table 1), indicating the mutal syn-stereochemical 
relationships between these five hydrogens. However, no ROESY correlations were observed 
between H-9a and H-9, or H-9a and H-17. These data suggested the α-configuration of the 
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proton at C-9a, which is opposite to that found in compounds 1 and 5. ROESY correlations 
were also observed between H-1α and H-2α, H-3, H-5α, H-8, and H-10; and H-2α and H-3. 
These observations indicated the α-configuration of these protons. The ROESY correlations 
between H-18 and H-19and; H-19 and H-20; and H-19 and H-22 indicated the 
relative syn-configuration between H-18 and H-20 of the -lactone moiety (Figure 3). 
Because of the relatively free rotation around the C-3−C-18 bond in both possible 
diastereomeric structures for 3 ((3S, 18S, 20S)-3 or (3S, 18R, 20R)-3), it was not possible to 
confidently assign the relative configurations of these two vicinal (C-3 and C-18) 
stereocentres from molecular modelling and ROESY NMR studies. However, we have 
tentatively assign the 3S, 18S, 20S configuration to 3 since this is the most commonly found 
absolute configuration of the Stemona alkaloids (Greger 2006; Kongkiatpaiboon, 2001; Pilli 
et al., 2010, 2005). The configurations assigned to C-11 and C-12 in 3 were based on ROESY 
correlations and the magnitude of J11,12 when compared to the known Stemona alkaloids 
11S,12S-saxorumamide (ROESY correlation between H-12 and H-17, and J11,12 = 2.0 Hz) 
and 11S,12R-isosaxorumamide (ROESY correlation between H-10 and H-13, and J11,12 = 6.9 
Hz) (Wang et al., 2007) and related dihydrostemofoline alkaloids (Mungkornasawakul et al., 
2004b). The relative small J11,12 value for 3 (1.3 Hz) and the ROESY correlations between H-
12 and H-17, as well as the correlation between H-11 and H-17, are consistent with the 
relative 11S,12S configurations assigned to compound 3. Detailed analysis of the 1H and 13C-
NMR spectra of 3, as well as 2D-NMR analyses (COSY, HMBC and ROESY, Table 1) 
established the complete structure and relative configuration of 3.  
Compound 4 was obtained as a pale yellow gum. The molecular formula of 4 as 
C23H32NO6 was determined from its HRESIMS (m/z 418.2230 [M+H]
+, calcd for C23H32NO6 
418.2226). The IR spectrum of 4 showed characteristic signals at 1780 cm-1 and at 1745 and 
1670 cm-1 for a saturated and an unsaturated -lactone ring, respectively. The 13C/DEPT 
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NMR spectrum of 4 displayed resonances for three methyl [δ 8.7 (C-17), 14.6 (C-22), and 
16.6 (C-16)], six methylene [δ 49.5 (C-5), 33.1 (C-7), 35.0 (C-19), 25.9 (C-2), 25.9 (C-1), 
and 17.8 (C-6)], five methine [δ 67.5 (C-3), 61.8 (C-9a), 50.9 (C-9), 41.7 (C-10), and 34.6 
(C-20)], two oxymethine [δ 77.2 (C-18) and 82.7 (C-8)], four olefinic [δ 163.6 (C-13), 98.1 
(C-14), 126.1 (C-12), and 149.2 (C-11)] and two quaternary [δ 178.3 (C-21) and 170.6 (C-15) 
carbons and a methoxy group [ 59.5 (C-23)] (Table 1). The chemical shifts of these 13C 
NMR signals were similar to these of the known Stemona alkaloids, protostemonine (the 
11(Z) isomer of 2) and isoprotostemonine (2) which were isolated previously from S. 
japonica (Ye et al., 1994). The COSY and HMBC spectroscopic analysis of 4 showed 
analogous correlations to those observed for 3. The correlations in the COSY spectrum of 4 
indicated the spin system H-1−H-2−H-3−H-18−H-19−H-20−H-22, typical of the pyrrolidine 
ring of the Stemona alkaloids with a -lactone substituent at C-3 (Figure 4). COSY 
correlations were also observed between the vicinal pairs of contiguous protons along the C-
5−C-6−C-7−C-8−C-9−C-9a−C-1 backbone and between H-10 and H-17 (Figure 4). The 1H 
NMR/COSY spectra indicated resonances for the presence of two methyl groups (δ 1.27 (d, J 
= 7.0 Hz, 3H, H-22), and 1.48 (d, J = 7.0 Hz, 3H, H-17), which were attached to methine 
groups with 1H NMR resonances at δ 2.70 (ddq, J = 7.0, 7.5, 11.5 Hz, 1H, H-20), and  3.04 
(ddd, J = 7.1, 7.1, 13.4, 1H, H-10), respectively. The HMBC experiment identified another 
methyl group at δ 2.02 (s, 3H) which was clearly attached to C-14 from the correlation 
between Me-16 and C-15. Key HMBC correlations are indicated in Figure 4, while full 
details are provided in Table 2. While compound 4 had the same molecular formula, and 
related structure features, to isoprotostemonine 2 and protostemonine there were notable 
differences in their NMR spectroscopic data (Wang et al., 2007). The aforementioned two 
known alkaloids had very similar 13C NMR chemical shifts, while those of 4 were 
significantly different, especially those for C-3 ( 64.4/64.3 vs  67.5 for 4), C-5 ( 46.6/46.5 
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vs  49.5 for 4), C-9a ( 58.4/58.8 vs  61.8 for 4) and C-18 ( 83.3/83.9 vs  77.2 for 4). 
These chemical shift differences indicated that 4 was diastereomer of these known alkaloids. 
Compound 4 showed NOESY correlations between H-18 and H-19β; and H-19β and Me-22 
(Figure 5 and Table 2), indicating the syn-relationship between H-18, H-19 and Me-22. 
ROESY correlations were also observed between H-9a and H-1β and H-9; H-1β and H-2β; 
H-2β and H-3; and H-9 and H-17, indicating the syn-relationship between these pairs of 
protons and the relative β-configuration of H-3. Because of the relatively free rotation around 
the C-3−C-18 bond in both possible diastereomeric structures for 4 [(3R, 18S, 20R)-4 or (3R, 
18R, 20S)-4], it was not possible to confidently assign the relative configurations of these two 
vicinal (C-3 and C-18) stereocentres from molecular modelling and NOESY NMR studies. 
However, we have tentatively assign the 3R, 18S, 20R configuration to 4 since the 18S 
configuration is the most commonly found absolute configuration of the Stemona alkaloids 
(Greger 2006; Kongkiatpaiboon, 2001; Pilli et al., 2010, 2005). The lack of a NOESY 
correlations between the OMe group and the protons on the C-ring was consistent the E-
configuration of the C-11−C-12 alkene. These NOESY studies indicated that compound 4 
was an epimer of 2 at C-3 and C-20 (see Table 2). Detailed analysis of the 1H and 13C-NMR 
spectra of 4, as well as 2D-NMR analyses (COSY, HMBC and NOESY, Table 2) established 
the complete structure and relative configuration of 4. 
Compounds 1–4 and protostemonine were examined for their antiplasmodial, 
cytotoxicity and human acetylcholinesterase (hAChE) inhibitory activities (Table 3). 
Compounds 1, 2 and protostemonine demonstrated moderate in vitro antiplasmodial activity 
against the P. falciparum strains, TM4 (a wild type chloroquine and antifolate sensitive 
strain) with IC50 values of 17.7µg/mL, 16.8 µg/mL and 16.0 µg/mL, respectively, and K1 
(multidrug resistant strain) with IC50 values of 16.8 µg/mL, 14.1 µg/mL and 11.9 µg/mL, 
respectively. Compounds 3 and 4 did not show antiplasmodial activity even at the highest 
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tested concentration of 38.9-41.7 µg/mL. However, none of these isolated alkaloids showed 
mammalian cell line (KB and Vero cells) toxicity or human acetylcholinesterase inhibitory 
activity (Table 3). 
3. Experimental 
3.1 General experimental procedures 
The IR spectra were recorded on a MIRacle 10 Shimadzu Spectrometer and optical rotations 
on a Jasco P-2000 polarimeter. The ESIMS and HRESIMS were recorded on a Micromass 
Platform LCZ and factory modified Waters QToF Ultima Mass Spectrometer (Wyntheshawe, 
UK). NMR spectra were recorded on a Varian-500 MHz NMR spectrometer. Silica gel was 
used for column chromatography and TLC was carried out on silica gel 60 GF254 plates 
Merck HX1 15287. The TLC spots were visualized by Dragendorff’s reagent. 
3.2 Plant material 
The material was identified at the Conservation Institute of Purwodadi Botanical Garden, 
Pasuruan, East of Java, Indonesia, where a voucher specimen (No. IV.D.IV.7) was deposited.  
3.3 Extraction and isolation 
The dry, ground roots of S. javanica (1.3 kg) were extracted with 95% MeOH (4 × 1000 mL) 
over 3 days at room temperature. The MeOH solution was evaporated to give a dark residue 
(35.2 g). The residue was chromatographed on silica gel (200 mL) using gradient elution 
from CH2Cl2/MeOH (0:10) to CH2Cl2/MeOH (8:2). A total of 4 L of eluent was collected in 
test tubes of 200 mL. These fractions were pooled on the basis of TLC analysis to give three 
alkaloid fractions; A (2.2 g), B (5.2 g) and C (1.2 g). A portion of fraction A (100 mg) was 
further separated by preparative thin layer chromatography (PTLC) using n-hexane/EtOAc 
(1:9) as the eluent to give isomaistemonine (2.5 mg) and protostemonine (55.3 mg). Fraction 
B (2.5 g) was then separated by column chromatography using isocratic eluent 
(CH2Cl2/MeOH; 8:2) to give fraction B1 (507 g) and B2 (700 mg). A portion of fraction B1 
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(240 mg) was further purified by PTLC (n-hexane/EtOAc (9:1)) and gave 8.3 mg of pure 13-
demethoxy-(11S*,12R*)-dihydroprotostemonine (1) and javastemonine A (3, 11.7 mg). 
Fraction B2 (700 mg) was chromatographed on silica gel (n-hexane/EtOAc (9:1)) to give 
isoprotostemonine (2, 30 mg). A portion of fraction C (130 mg) was further chromatograped 
by PTLC (n-hexane/EtOAc (9:1)) to give javastemonine B (4, 49.7 mg).  
3.3.1 Javastemonine A (3) 
Brown gum; []23D +35.5 (c 0.09, CHCl3); IR film νmax 3436, 2963, 2874, 1771, 1761, 
1657, 1455, 1159, 1044, 726 cm-1; 1H NMR (CDCl3, 500 MHz) and 
13C NMR (CDCl3, 125 
MHz) see Table 1; HRESIMS m/z 390. 2280 [M + H]+ (calcd for C22H32NO5 390.2291). 
3.3.2 Javastemonine B (4) 
Brown gum; []23D -45.2 (c 0.01, CHCl3); IR film νmax 2940, 1780, 1745, 1670, 1610, 1455, 
1399, 1195, 1165, 1000 cm-1; 1H NMR (CDCl3, 500 MHz) and 
13C NMR (CDCl3, 125 MHz) 
see Table 2; HRESIMS m/z 418.2230 [M + H]+ (calcd for C23H32NO6 418.2226). 
3.4 Bioassay methodology 
3.4.1 Antiplasmodial assay 
Compounds 1−4 and protostemonine were tested in vitro against a multidrug resistant 
K1CB1 strain and a wild type chloroquine and antifolate sensitive TM4/8.2 strain of 
Plasmodium falciparum using a previously described method (Trager and Jensen, 1976; 
Wangchuk et al., 2011; Desjardins et al., 1979; Kamchonwongpaisan et al., 2004). 
3.4.2  Cytotoxicity assay  
Cytotoxicity assays against normal Vero cells from kidney of African green monkey, 
Cecopithecus aethiops and human oral carcinoma KB cells were performed as previously 
described (Wangchuk et al., 2012). 
3.4.3 hAChE inhibitory assays 
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Fig. 2. Key COSY and HMBC correlations for compound 3. 
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Fig. 3. Spartan ‘10 generated lowest energy conformation of 3 showing key ROESY cross-
peaks. The structures shown here and in Figure 5 were generated using Spartan ‘10 and 












Table 1  
13C NMR (125 Hz), 1H NMR (500 MHz) and 2D spectroscopic data for compound 3 in 
CDCl3. 
Position δC (DEPT) δH (mult., J (Hz) HMBC  ROESY  COSY  
1α 26.9 1.69-1.61 (overlap)  2, 3 2α, 3, 5α, 8, 9a, 10 2, 9a 
1β  1.94-1.90 (overlap)   2β  
2α 26.8 1.91-185 (overlap)  1, 3 1α, 3, 9a, 10 1, 3 
2β  1.50-1.42 (overlap)  1β, 18  
3 65.1 3.23 (ddd, 6.6, 7.0, 10.0) 1, 2, 5, 18 1α, 2α, 5β, 9a, 18, 19α 2, 18 
5α 48.0 3.47 (dd, 15.3, 5.0) 3 1α, 5β, 8 6 
5β  2.96 (dd, 15.3, 11.5)  3, 5α, 9  
6α 19.8 1.56-1.51 (overlap)  7 - 5, 7 
6β  1.50-1.42 (overlap)    -  
7α 35.3 2.08 (dd, 3.0, 8.7) 5, 9 8 6, 8 
7β  1.38-1.29 (m)   -  
8 80.6 3.83-3.79 (m, overlap) 7, 9a 1α, 5α ,7α, 10 7, 9 
9 54.6 2.04-1.99 (m) 1, 17 5β, 11, 17 8, 9a, 10 
9a 59.7 3.77-3.75 (overlap) 1, 2, 5 1α, 2α, 3, 10 1, 9 
10 39.8 2.25-2.17 (m) 9, 17 1α, 2α, 8, 9a, 12, 17 9, 11, 17 
11 83.5 3.82-3.78 (overlap) 7 9, 12, 13, 17 10, 12 
12 80.7 4.90 (d, 1.3) 10, 11, 13 10, 11, 13, 17 11, 13 
13 146.4 7.00 (br s) 16 11, 12, 16 12 
14 131.2 - 16 - - 
15 174.5 - 13, 16 - - 
16 11.0 1.95 (s)  13 - 
17 15.9 1.10 (d, 6.5) 11 9, 10, 11, 12 10 
18 82.6 4.31 (ddd, 5.5, 7.4, 12.8) 2, 3, 19 3, 2β, 19β, 20 3, 19 
19α 34.9 1.55-1.49 (m)  20, 22 3, 22 18, 20 
19β  2.40 (ddd, 5.4, 8.3, 12.0)                     18, 20  
20 35.1 2.66-2.58 (m) 19, 22 18, 19β, 22 19, 22 
21 179.5 - 19, 22 - - 
22 15.1 1.26 (d, 7.0) 19, 20 19α, 20 20 
 
 






Fig. 5. Spartan ‘10 generated lowest energy conformation of 4 showing key ROESY cross-
peaks. 
Table 2  
13C NMR (125 Hz), 1H NMR (500 MHz) and 2D spectroscopic data for compound 4 in 
CDCl3. 
Position δC (DEPT) δH (mult., J (Hz) HMBC  ROESY  COSY  
1α 25.9 1.92-1.86 (overlap) 2 1β, 2α, 8, 19α 2, 9a 
1β  2.24-2.16 (overlap)  1α, 2β, 9a, 10  
2α 25.9 2.18-2.10 (overlap) 1 1α, 2β, 19α,10 1, 3 
2β  1.86-1.80 (overlap)  1β, 2α, 3, 9a, 18,   
3 67.5 3.63 (m) 1, 2, 5, 19 2β, 19β 2, 18 
5α 49.5 3.79 (dd, 6.0, 14.7) 7 5β, 6α, 18, 19β 6 
5β  3.35 (dd, 12.5, 14.7)  5α, 5β, 6α, 6β, 9  
6α 17.8 1.86-1.82 (m) 5 5α, 6β, 7α, 8 5, 7 
6β  1.98-1.92 (m)  5β, 6α, 7β  
7α 33.1 2.44 (dd, 3.7, 12.6) 5 6α, 7β, 8 6, 8 
7β  1.66-1.58 (overlap)  6β, 7α, 9  
8 82.7 4.30  (ddd, 3.9, 11.0, 15.0) 7, 9 1α, 6α, 7α, 10 7, 9 
9 50.9 2.29 (ddd, 4.0, 10.7, 14.6)   10 5β, 7β, 9a, 17 8, 9a 
9a 61.8 4.36 (ddd, 6.2, 10.9, 11.1) 1, 2, 5, 9, 10 1β, 2β, 9, 17 1, 9 
10 41.7 3.04 (ddd, 7.1, 7.1, 13.4) 9, 17 1β, 2α, 8, 17 9, 17 
11 149.2 - 10, 17 - - 
12 126.1 - 10, 17 - - 
13 163.6 - 23 - - 
14 98.1 - 16 - - 
15 170.6 - 16 - - 
16 16.6 2.02 (s) - 23 - 
17 8.7 1.48 (d, 7.0) 9, 10 9, 9a, 10  10 
18 77.2 5.03 (ddd, 6.4, 6.4, 9.7) 19 2β, 5α, 19β 3, 19 
19α 35.0 2.54 (ddd, 5.6, 8.3, 12.6) 20, 22 1α, 2α, 19β, 20 18, 20 
19β  1.64-1.54 (overlap)  3, 5α, 18, 19α, 22  
20 34.6 2.70 (ddq, 7.0, 7.5, 11.5)  19, 22 19, 22 19, 22 
21 178.3 - 19, 20, 22 - - 
22 14.6 1.27 (d, 7.0) 19, 20 19β, 20 20 
23 59.5 4.11 (s) - 16 - 
20 
 
Table 3  
Antiplasmodial (IC50 in µg/mL), cytotoxicity and human acetylcholinesterase inhibitory 
activities of the alkaloids 1-4 and protostemonine. 
Compounds Antiplasmodial (µg/mL) Cytotoxicity (µg/mL) hAChE (µM) 
 TM4 K1 VERO KB  
13-Demethoxy-11(S*),12(R*)-
dihydroprotostemonine (1) 
17.7 ± 3.7   16.8 ± 3.1 > 38.9 > 38.9 >100 
Protostemonine 16.8 ± 5.4  14.1 ± 3.7 > 41.7 > 41.7 >100 
Isoprotostemonine (2) 16.0 ± 4.2  11.9 ± 3.3 > 41.7   >41.7 >100 
Javastemonine A (3) > 38.9 > 38.9 > 38.9 > 38.9 >100 
Javastemonine B (4) > 41.7 > 41.7 > 41.7 > 41.7 >100 
Chloroquinea  0.010  0.089 - - - 
Cycloguanila 0.009  0.810 - - - 
Pyrimethaminea 0.020  7.700  - - - 
Ellipticineb - - 0.093 - - 
Doxorubicinb - - - 0.56 - 
Galanthamineb - - - - 0.55 
areference drugs for antiplasmodial activity.  
breference drugs for cytotoxicity activity. 
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 Two new alkaloids, javastemonine A and B, isolated from Stemona javanica.  
 Structural elucidations were made using spectroscopic analysis.  
 Javastemonine A was a C-9a epimer of stemocichinine.  
 Javastemonine B was a C-3 epimer of isoprotostemonine. 
 Three known alkaloids isolated were active against Plasmodiyum falciparum. 
